CARL vs NVST · rev $50.5M vs P/E 56, rev $1.44B
Carlsmed, Inc. Common Stock (CARL) versus Envista Holdings Corp (NVST) — a side-by-side from cached financials, not a winner call.
Carlsmed, Inc. Common Stock (CARL) is a health information services company listed on NASDAQ.
Envista Holdings Corp (NVST) is a medical instruments & supplies company listed on US.
Latest reported CARL revenue for 2025-12-31 was $50.5M. Net income was -$29.6M. Revenue was up 85.9% from 2024-12-31 to 2025-12-31. CARL currently screens at market cap $299.7M.
Latest reported NVST revenue for 2026-07-03 was $1.44B. Net income was $92.4M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
CARL currently screens at market cap $299.7M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
Not investment advice. Open the CARL and NVST stock pages for the full models.
Not investment advice.